GGrantIndex
Sort

172,184 grants matching inflammation

Early Life Adversity, Biological Embedding, and Risk for Developmental Precursors of Mental Disorders

$2,499,658
Joan L Luby · Washington University · R01 · FY2024 · MH

Expression, Structure/function, Regulation, and Roles of PDE3 Isoforms

$2,499,647
Vincent Manganiello · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory

$2,499,382
Rima F Kaddurah-Daouk · Duke University · U01 · FY2024 · AG

Interdisciplinary research in vascular biology

$2,498,582
Rodger Paul McEver · Oklahoma Medical Research Foundation · P20 · FY2014 · GM

PATHOPHYSIOLOGY OF THE ENDOTHELIUM

$2,498,374
Michael A Gimbrone · Brigham And Women'S Hospital · P01 · FY2007 · HL

Clinical Evaluation of PET Radiotracers

$2,498,356
Robert Innis · National Institute Of Mental Health · ZIA · FY2018 · MH

MOLECULAR/CLINICAL APPROACHES TO COLON CANCER PRECURSORS

$2,497,978
Randall Walter Burt · University Of Utah · P01 · FY2006 · CA

Competing Renewal P01

$2,497,521
Vishwa Deep Dixit · Yale University · P01 · FY2022 · AG

Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease

$2,497,417
Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES

Epidemiology of Diabetes Interventions and Complications Data Coordinating Center

$2,496,965
John M Lachin · George Washington University · U01 · FY2014 · DK

Epigenetic, Protein, and Cellular Biomarkers of Beta Cell Function in T1D

$2,496,787
Kevan C Herold · Yale University · UC4 · FY2014 · DK

Role of microbiome in cancer and inflammation

$2,496,470
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Neuroinflammatory mechanisms of aging-related vascular cognitive impairment (VCI)

$2,495,260
Nabil J. Alkayed · Oregon Health & Science University · RF1 · FY2017 · AG

A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease

$2,494,955
Howard Feldman · University Of California, San Diego · R01 · FY2023 · AG

Genetics of Atherosclerosis in Mexican Americans

$2,494,758
John Blangero · Texas Biomedical Research Institute · P01 · FY2006 · HL

Pathophysiology of Acute Pain in Patients with Sickle Cell Disease

$2,494,416
Swee Lay Thein · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL

Cell Interactions in Vascular Injury and Atherogenesis

$2,494,295
Katherine Amberson Hajjar · Weill Medical Coll Of Cornell Univ · P01 · FY2008 · HL

Trial to Assess Chelation Therapy (TACT)

$2,494,247
Gervasio A Lamas · University Of Miami School Of Medicine · U01 · FY2008 · HL

Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis

$2,494,008
Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2020 · HL

Cancer Risk in Human Populations

$2,493,437
Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

MOLECULAR/CLINICAL APPROACHES TO COLON CANCER PRECURSORS

$2,493,256
University Of Utah · P01 · FY2005 · CA

PATHOPHYSIOLOGY OF THE ENDOTHELIUM

$2,493,178
Brigham And Women'S Hospital · P01 · FY2005 · HL

The Morehouse School of Medicine's Institute of Genomic Medicine Center for Genomic Diversity

$2,492,722
Melissa B Davis · Morehouse School Of Medicine · U54 · FY2024 · HG

A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?

$2,492,476
Christopher K Glass · University Of California, San Diego · P01 · FY2023 · HL

Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)

$2,491,998
Elaine Janine Abrams · Columbia University Health Sciences · R01 · FY2022 · HD